Michael Phalen, executive vice president and group president at Boston Scientific, sold 35,000 shares of the company, according to a Press Telegraph report.
Here are four things to know:
1. The shares were sold at an average of $24 per share, for a total transaction value of $841,050.
2. Currently, Mr. Phalen owns a total of 91,733 shares.
3. Out of 18 analysts covering Boston Scientific, 14 rate it a "buy," zero rate it "sell," while four rate it "hold."
4. The company has a market cap of $33.15 billion.